Intezyne Technologies, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2004-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.intezyne.com
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Safety and Pharmacokinetic Study of IT-141 in Monotherapy in Patients With Advanced Cancer
Phase 1
Terminated
- Conditions
- CancerNeoplasmsTumorsRefractory Solid TumorsRecurrent Solid Tumors
- Interventions
- First Posted Date
- 2017-03-30
- Last Posted Date
- 2020-12-22
- Lead Sponsor
- Intezyne Technologies, Inc.
- Target Recruit Count
- 10
- Registration Number
- NCT03096340
- Locations
- 🇺🇸
Mary Crowley Cancer Research Centers - Medical City, Dallas, Texas, United States
🇺🇸Seattle Cancer Care Alliance, Seattle, Washington, United States
News
No news found